CL.CN
Cresco Labs Inc
Price:  
1.01 
CAD
Volume:  
407,700.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CL.CN WACC - Weighted Average Cost of Capital

The WACC of Cresco Labs Inc (CL.CN) is 7.6%.

The Cost of Equity of Cresco Labs Inc (CL.CN) is 8.10%.
The Cost of Debt of Cresco Labs Inc (CL.CN) is 10.85%.

Range Selected
Cost of equity 6.50% - 9.70% 8.10%
Tax rate 26.00% - 34.90% 30.45%
Cost of debt 6.80% - 14.90% 10.85%
WACC 5.5% - 9.7% 7.6%
WACC

CL.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.65 0.91
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.50% 9.70%
Tax rate 26.00% 34.90%
Debt/Equity ratio 2.2 2.2
Cost of debt 6.80% 14.90%
After-tax WACC 5.5% 9.7%
Selected WACC 7.6%